The European Investment Bank and the European Fund for Sustainable Development provided on Tuesday an additional €500 million to COVAX in order to ensure that 92 low and middle-income countries receive access to COVID-19 vaccines, APA reports citing Teletrader.
"The European Commission and EIB's combined support of €500 million will enable COVAX to make one billion doses of vaccines available as rapidly as possible to people in low and middle-income countries," noted the Commission's President Ursula von der Leyen.
"The success of several vaccine programs, notably BioNTech's, backed by the European Commission and the European Investment Bank, is giving the world hope that recovery is closer," insisted President of the European Investment Bank, Werner Hoyer. Earlier in the day, a report suggested the European Medicines Agency could approve the Pfizer-BioNTech vaccine before the end of the year.
The latest efforts by the European Union attempt to enable countries from Africa, Asia, the Caribbean and the Pacific to obtain needed vaccine doses. The number of coronavirus cases across Africa has been very low according to the official data, as just over 2.4 million COVID-19 cases were registered in total. On the other hand, India and the Middle East have seen a very significant amount of positive cases over the year.